Physico chemical characterization of a novel anti-cancer agent and its comparison to Taxol^®

References

• http://www.cancer.gov/cancertopics/factsheet/nci/drugdiscovery/print. Accessed on 05 March 2011
   Google Scholar
• Holmes FA. Current status of clinical trials with paclitaxel and docetaxel in Taxane Anticancer Agents: Basic science and current status. ACS Symposium Series. 1995. Washington, D.C.
   Google Scholar
• Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1977;277:665–667.
   Web of Science ®Google Scholar
• Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993;7:563–568.
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wendell K, Gardiner S. Mitotic block induced in HeLa cells by low concentration of paclitaxel (Taxol)results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996;56:816–825.
   PubMed Web of Science ®Google Scholar
• Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 1996;88:1308–1314.
   PubMed Web of Science ®Google Scholar
• Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997;57:229–233.
   PubMed Web of Science ®Google Scholar
• Yeung TK, Germond C, Chen X, Wang Z. The mode of action of Taxol: Apoptosis at low concentration and necrosis at high concentration. Biochem Biophys Res 1999;263:398–404.
   PubMed Web of Science ®Google Scholar
• Benet LZ, Goyan JE. Potentiometric determination of dissociation constants. J Pharm Sci 1967;56:665–680.
   PubMed Web of Science ®Google Scholar
• Moriguchi I. Simple methods for calculating octanol/water partition coefficient. Chem Pharm Bull 1992;40:127–130.
   Web of Science ®Google Scholar
• Hansch C, Taylor JB, Sammes PG. Comprehensive Medicinal Chemistry: Cumulative Subject Index and Drug Compendium. Oxford: Pergamon Press,1991.
   Google Scholar
• Wohnsland F, Faller B. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J Med Chem 2001;44:923–930.
   PubMed Web of Science ®Google Scholar
• Yazdamian M, Glynn SL, Wright JL, Hawi A. Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compound. Pharm Res 1998;15:1490–1494.
   PubMed Web of Science ®Google Scholar
• Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption process. J Med Chem 1998;41:1007–1010.
   PubMed Web of Science ®Google Scholar
• Liu H, Sabus C, Carter GT, Du C, Avdeef A, Tischler M. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection. Pharm Res 2003;20:1820–1826.
   PubMed Web of Science ®Google Scholar
• Ruell JA, Tsinman O, Avdeef A. PAMPA - a drug absorption in vitro model 5. Unstirred water layer in iso-pH mapping assay and pKa flux-optimized design (pOD-PAMPA). Eur J Pharm Sci 2003;20:393–402.
   PubMed Web of Science ®Google Scholar
• Sugano K, Nabuchi Y, Machida M, Aso Y. Prediction of human intestinal permeability using artificial membrane permeability. Int J Pharm 2003;257:245–251.
   PubMed Web of Science ®Google Scholar
• Dallas AJ, Carr PW. A thermodynamic and solvatochromic investigation of the effect of water on the phase-transfer properties of octan-1-ol. J Chem Soc, Perkin Trans 2 1992;2155–2161.
   Google Scholar
• Hefter GT. Alcohols with water. Solubility Data Series 1984;15:364–381.
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Mwatamba K, Torrado S, Bandera C, Gordo PF, Torrado JJ. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm 2004;272:29–36.
   PubMed Web of Science ®Google Scholar
• Datta S, Grant DJW. Crystal structures of drugs: advances in determination, prediction and engineering. Nat Rev Drug Discovery 2004;3:42–57.
   PubMed Web of Science ®Google Scholar
• Morisette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR. High-throughput crystallization: Polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Delivery Rev 2004;56:275–300.
   PubMed Web of Science ®Google Scholar
• Roy S, Aitipamula S, Nangia A. Thermochemical analysis of Venlafaxine Hydrochloride polymorphs 1-5. Cryst Growth Des 2005;5:2268–2276.
   Web of Science ®Google Scholar
• Abu Zanat FZ, Qandil AM, Tashtoush BM. A promising codrug of nicotinic acid and ibuprofen for managing dislipidemia. I: Synthesis and in vitro evaluation. Drug Dev Ind Pharm 2011;37:1090–1099.
   PubMed Web of Science ®Google Scholar
• Hidalgo IJ. Assessing the absorption of new pharmaceuticals. Current Topics Med Chem 2001;1:385–401.
   PubMedGoogle Scholar
• Obata K, Sugano K, Machida M, Aso Y. Biopharmaceutics classification by high-throughput solubility assay and PAMPA. Drug Dev Ind Pharm 2004;30:181–185.
   PubMed Web of Science ®Google Scholar
• Avdeef A, Artursson P, Neuhoff S, Lazarova L, Garasjo J, Travelin S. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKaflux method. Eur J Pharm Sci 2005;24:333–349.
   PubMed Web of Science ®Google Scholar
• Tian J, Stella VJ. Degradation of paclitaxel and related compounds in aqueous solutions II: Nonepimerization degradation uder neutral to basic pH conditions. J Pharm Sci 2008;97:3100–3101.
   PubMed Web of Science ®Google Scholar
• Smrdel P, Grabnar I, Locatelli I, Cerne M, Andrensek S, Kovacic N, Kristl A, Bogataj M, Urleb U, Mrhar A. Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423-a new phthalimido-desmuramyl-dipeptide derivative with immunomodulationg activity. Drug Dev Ind Pharm 2009;35:1293–1301.
   PubMed Web of Science ®Google Scholar
• Wife RL, Tijhuis J. Library Quality Metrices. In: MS, Chorghade, ed. Drug discovery and development: Drug development. Hoboken, NJ: John Wiley & Sons, Inc., 2007:265–278.
   Google Scholar
• Kozikowski BA, Burt TM, Tirey DA, Williams LE, Kuzmak BR, Stanton DT, Morand KL, Nelson SL. The effect of room-temperature storage on the stability of compounds in DMSO. J Biomol Screen 2003;8:205–209.
   PubMed Web of Science ®Google Scholar
• Dordunoo SK, Burt HM. Solubility and stability of taxol: effects of buffer and cyclodextrins. Int J Pharm 1996;133:191–201.
   Web of Science ®Google Scholar
• Liggins RT, Hunter WL, Burt HM. Solid-state characterization of paclitaxel. J Pharm Sci 1997;86:1458–1463.
   PubMed Web of Science ®Google Scholar
• Sharma US, Balasubramanian SV, Straubinger RM. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrin. J Pharm Sci 1995;84:1223–1230.
   PubMed Web of Science ®Google Scholar
• http://www.jtbaker.com/msds/englishhtml/t4823.htm. Accessed on 12 February 2011.
   Google Scholar